Molecular Profiling and Matched Targeted Therapy for Patients With Unresectable Advanced or Metastatic Melanoma
Clinical trial NCT02645149 · COMPLETED
Trial details
- NCT number
- NCT02645149
- Sponsor
- Melanoma Institute Australia
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-22
- Primary completion
- 2025-11-01
- Enrollment
- 216
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.